The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of ...
ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its ...
We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...
6don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach. A newly ...
SANAC urges local production of HIV prevention drug Lenacapavir to boost South Africa’s health independence and fight the HIV ...
JOHANNESBURG - Lenacapavir is described as a gamechanger in the fight against HIV/Aids. The long-acting prevention injection only needs to be administered twice a year. The National AIDS Council and ...
One in 10 clinics in SA will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines ...
The South African on MSN
Lenacapavir rollout in South Africa and PEPFAR builds momentum
South Africa advances HIV prevention with the lenacapavir rollout in 2026, and the US approves the PEPFAR Bridge Plan for six ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback